Boston Scientific Wins FDA Approval for Resonate Family Devices

May 10, 2017

Boston Scientific has received FDA approval for the Resonate family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems.

The approval includes multisite pacing and compatibility with the HeartLogic heart failure diagnostic service to help physicians improve heart failure management.

The devices received a CE mark in February 2017.

View today's stories